Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/2/2025

Treatment of Reassurance-Seeking OCD

Introduction to Reassurance-Seeking OCD

  • The American Psychological Association recommends cognitive-behavioral therapy (CBT) with exposure and response prevention (ERP) as the primary treatment for reassurance-seeking OCD, where the "response prevention" component specifically targets the compulsive reassurance-seeking behavior by instructing patients to abstain from seeking reassurance while being exposed to uncertainty-provoking situations 1
  • Reassurance-seeking is a compulsive behavior in OCD where patients repeatedly ask others for confirmation that their feared outcomes won't occur, temporarily reducing anxiety but perpetuating the OCD cycle by preventing patients from learning to tolerate uncertainty 2

First-Line Treatment: CBT with ERP

  • CBT with exposure and response prevention is the treatment of choice, with a number needed to treat of 3 compared to 5 for SSRIs, and should consist of 10-20 sessions of individual or group CBT with ERP, delivered in-person or via internet-based protocols 1, 3
  • The treatment should include gradual exposure to uncertainty-provoking situations while specifically abstaining from seeking reassurance, and integration of cognitive reappraisal with ERP to discuss feared consequences and dysfunctional beliefs about uncertainty 2, 1
  • Between-session homework, specifically practicing ERP exercises at home without seeking reassurance, is the strongest predictor of good outcome 1

Medication Treatment

  • If CBT expertise is unavailable, patient prefers medication, severe comorbid depression is present, or OCD severity precludes active participation in psychotherapy, initiate an SSRI at higher-than-depression doses 1, 4
  • All SSRIs show similar efficacy; select based on adverse effect profiles, drug interactions, and comorbid conditions 1
  • Allow 8-12 weeks at maximum tolerated dose before declaring treatment failure, and continue treatment for a minimum of 12-24 months after achieving remission due to high relapse risk 1, 4

Combination Therapy and Treatment-Resistant Cases

  • Beginning with combined CBT plus SSRI is appropriate for moderate-to-severe OCD, including severe reassurance-seeking behavior 1
  • If initial treatment fails after adequate trials, consider switching to a different SSRI or trying higher doses, adding antipsychotic augmentation, or using clomipramine, which is more efficacious than SSRIs in meta-analyses but has lower tolerability 4
  • Intensive CBT protocols with multiple sessions over days, sometimes inpatient, and deep repetitive transcranial magnetic stimulation (FDA-approved for OCD) may also be considered for treatment-resistant cases 4, 3

Critical Pitfalls and Monitoring

  • A major pitfall in treating reassurance-seeking OCD is family accommodation, where family members provide reassurance in response to the patient's requests, maintaining the OCD cycle and undermining treatment 2
  • Psychoeducation must include family members whenever possible, addressing their role in inadvertently maintaining OCD through accommodation, and family members should be instructed to compassionately decline providing reassurance while supporting the patient's ERP work 2
  • Assess adherence to between-session homework (ERP exercises without seeking reassurance) as this is the strongest predictor of outcome, and monitor SSRI adverse effects when establishing optimal dose 1, 4

REFERENCES

1

First-Line Treatment for Obsessive-Compulsive Disorder (OCD) [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

2

obsessive-compulsive disorder. [LINK]

Nature Reviews Disease Primers, 2019

3

Treatment of OCD in Bipolar 2 Disorder [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Medications for Severe OCD and Anxiety [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025